Efficacy of the Novel Degludec/Aspart Insulin Co-formulation in Children and Adolescents with Type 1 Diabetes: A Real-life Experience with One Year of IDegAsp Therapy in Poorly Controlled and Non-compliant Patients

• Main Authors: Tarık Kırkgöz (Author), Mehmet Eltan (Author), Sare Betül Kaygusuz (Author), Zehra Yavaş Abalı (Author), Didem Helvacıoğlu (Author), Tuba Seven Menevşe (Author), Büşra Gürpınar Tosun (Author), Tülay Güran (Author), Abdullah Bereket (Author), Serap Demircioğlu (Author)
• Format: Book
• Published: Galenos Yayincilik, 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

INTRODUCTION: To evaluate the efficacy of degludec/aspart (IDegAsp) insulin co-formulation in children and adolescents with poorly controlled type 1 diabetes (T1DM). METHODS: Patients with poorly controlled T1DM on basal-bolus insulin regimes and having compliance problems related to insulin injecti...